5/11/22-Medication for Perinatal Opioid Use Disorder Part 1
Presentation Resources
A collaborative approach treatment pregnant women with opioid use disorders (SAMHSA)
Debelak, K., Morrone, W., O'Grady, K., & Jones, H. (2013). Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data. American Journal of Addiction, 22(3):252-4. Abstract only at
https://onlinelibrary.wiley.com/doi/10.1111/j.1521-0391.2012.12005.xFact Sheet-Neonatal Abstinence Syndrome Among Michigan Infants
Mullins, N. et al. (2019). Buprenorphine and Naloxone versus Buprenorphine for opioid use disorder in pregnancy: A cohort study. Journal of Addiction Medicine, 13(5), 24-34.
Abstract only at https://pubmed.ncbi.nlm.nih.gov/31567599/Opioid Use and Opioid Use Disorder in Pregnancy. Committee Opinion Number 711 (ACOG).
Tsai, L. C., & Doan, T. J. (2016). Breastfeeding among mothers on opioid maintenance treatment: A literature review. Journal of Human Lactation, 32(3), 521–529. Abstract only at https://doi.org/10.1177/0890334416641909
Young, J. L., & Martin, P. R. (2012). Treatment of opioid dependence in the setting of pregnancy. Psychiatric Clinics of North America, 35, 441-460.
Abstract and Key Points only at https://www.psych.theclinics.com/article/S0193-953X(12)00025-1/pdf